Si Bone Total Revenue Over Time
| SIBN Stock | USD 13.56 0.29 2.19% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Si Bone Performance and Si Bone Correlation. SIBN |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Si Bone. If investors know SIBN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Si Bone listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.91) | Revenue Per Share 3.817 | Quarterly Revenue Growth 0.186 | Return On Assets (0.12) | Return On Equity (0.22) |
The market value of Si Bone is measured differently than its book value, which is the value of SIBN that is recorded on the company's balance sheet. Investors also form their own opinion of Si Bone's value that differs from its market value or its book value, called intrinsic value, which is Si Bone's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Si Bone's market value can be influenced by many factors that don't directly affect Si Bone's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Si Bone's value and its price as these two are different measures arrived at by different means. Investors typically determine if Si Bone is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Si Bone's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Revenue Analysis
Compare Si Bone and related stocks such as NuVasive, CONMED, and Orthopediatrics Corp Total Revenue Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CNMD | 10.5 M | 725.1 M | 767.1 M | 756.8 M | 734.5 M | 719.2 M | 763.5 M | 796.4 M | 859.6 M | 955.1 M | 862.5 M | 1 B | 1 B | 1.2 B | 1.3 B |
| KIDS | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 31 M | 37.3 M | 45.6 M | 57.6 M | 72.6 M | 71.1 M | 98 M | 122.3 M | 148.7 M | 77.9 M |
| LUNG | 115 K | 115 K | 115 K | 115 K | 332 K | 19.4 K | 8.8 K | 0.0 | 20 M | 32.6 M | 32.7 M | 48.4 M | 53.7 M | 68.7 M | 72.1 M |
| IRMD | 7.7 M | 7.7 M | 7.7 M | 11.3 M | 15.7 M | 31.6 M | 32.5 M | 23.1 M | 30.4 M | 38.5 M | 31.7 M | 41.8 M | 53.3 M | 65.6 M | 35.1 M |
| OFIX | 20.9 M | 579 M | 462.3 M | 400.5 M | 402.3 M | 396.5 M | 409.8 M | 433.8 M | 453 M | 460 M | 406.6 M | 464.5 M | 460.7 M | 746.6 M | 784 M |
| NPCE | 37 M | 37 M | 37 M | 37 M | 37 M | 37 M | 37 M | 37 M | 37 M | 37 M | 41.1 M | 45.2 M | 45.5 M | 65.4 M | 51.5 M |
| ITGR | 79.2 M | 568.8 M | 646.2 M | 663.9 M | 687.8 M | 800.4 M | 1.4 B | 1.5 B | 1.2 B | 1.3 B | 1.1 B | 1.2 B | 1.4 B | 1.6 B | 1.7 B |
| SGHT | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 23.3 M | 27.6 M | 49 M | 71.3 M | 81.1 M | 47.6 M |
| RPID | 16.1 M | 11 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 16.1 M | 23.2 M | 17.1 M | 22.5 M | 19.3 M |
| TCMD | 37.2 M | 37.2 M | 37.2 M | 37.2 M | 47.7 M | 62.9 M | 84.5 M | 109.3 M | 143.8 M | 189.5 M | 187.1 M | 208.1 M | 246.8 M | 274.4 M | 159.1 M |
| RXST | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 14.7 M | 22.6 M | 49 M | 89.1 M | 93.5 M |
| AXGN | 4.7 M | 4.8 M | 7.7 M | 10.9 M | 16.8 M | 27.3 M | 41.1 M | 60.4 M | 83.9 M | 106.7 M | 112.3 M | 127.4 M | 138.6 M | 159 M | 167 M |
| TMCI | 39.4 M | 39.4 M | 39.4 M | 39.4 M | 39.4 M | 39.4 M | 39.4 M | 39.4 M | 39.4 M | 39.4 M | 57.4 M | 94.4 M | 141.8 M | 187.1 M | 114.4 M |
| ESTA | 9.6 M | 9.6 M | 9.6 M | 9.6 M | 9.6 M | 9.6 M | 19.8 M | 34.7 M | 61.2 M | 89.6 M | 84.7 M | 126.7 M | 161.7 M | 165.2 M | 92 M |
Si Bone and related stocks such as NuVasive, CONMED, and Orthopediatrics Corp Total Revenue description
Total revenue comprises all receipts Si Bone generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.My Equities
My Current Equities and Potential Positions
| Si Bone | SIBN |
Specialization | Health Care, Health Care Equipment & Services |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 13.56
Check out Si Bone Performance and Si Bone Correlation. To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Si Bone technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.